Austin Biosciences

Risk score

57
Large logo of Austin Biosciences

Headquarters

Flag of United States of AmericaUnited States of America

Austin Biosciences operates as a dynamic pharmaceutical firm based in Texas, dedicated to enhancing the effectiveness and safety of existing FDA approved drugs utilized for the treatment of various types of cancer such as breast, lung, prostate, gastric, head and neck, and ovarian cancer. The state-of-the-art research and development facilities located in Texas provide an excellent setting for scientists to develop pioneering treatments. The company is anticipated to commence a Phase 1 trial for its primary candidate Austin Biosciences-1103 in the first quarter of 2024 or earlier. Additionally, pre-clinical development is in progress for multiple potential products in their research pipeline.